Table 1.
Relationships Between lncRNA MT1JP and Pathological Characteristics
| n | MT1JP | x2/t | P | |
|---|---|---|---|---|
| Gender | 0.27 | 0.79 | ||
| Male | 70 | 0.71±0.18 | ||
| Female | 46 | 0.70±0.19 | ||
| Age (y) | 1.73 | 0.09 | ||
| <55 | 49 | 0.74±0.18 | ||
| ≥55 | 67 | 0.68±0.18 | ||
| Tumor size (cm) | 5.77 | <0.05 | ||
| ≥5 | 62 | 0.63±0.14 | ||
| <5 | 54 | 0.80±0.18 | ||
| Combined with hepatitis | 1.31 | 0.19 | ||
| Yes | 95 | 0.68±0.19 | ||
| No | 21 | 0.75±0.14 | ||
| AFP (ng/mL) | 6.96 | <0.05 | ||
| <200 | 40 | 0.84±0.14 | ||
| ≥200 | 76 | 0.64±0.16 | ||
| TNM stage | 6.11 | <0.05 | ||
| I+II | 47 | 0.82±0.15 | ||
| III+IV | 69 | 0.63±0.16 | ||
| Differentiation | 7.26 | <0.05 | ||
| Poor | 39 | 0.57±0.14 | ||
| Moderate + high | 77 | 0.78±0.16 | ||
| Lymph node metastasis | 7.85 | <0.05 | ||
| Yes | 65 | 0.61±0.14 | ||
| No | 51 | 0.83±0.15 |